• 1

    Centers for Disease Control and Prevention: National Diabetes Statistics Report, 2014, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, 2014.

    • Search Google Scholar
    • Export Citation
  • 2

    Boden G, Jadali F, Tappy L, et al: A radioimmunoassay for human insulin receptor correlation between insulin binding and receptor mass. Horm Metab Res 23: 117, 1991.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Kelley DE Mintun M, Watkins SC, et al: The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest 97: 2705, 1996.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Boden G, Tappy L, Jadali F, et al: Role of glucagon in disposal of an amino acid load. Am Physiol 259: E225, 1990.

  • 5

    Boden G, Jadali F: Effect of lipid on basal carbohydrate metabolism in normal men. Diabetes 40: 686, 1991.

  • 6

    Boden G, Jadali F, White J, et al: Effect of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88: 960, 1991.

  • 7

    American Diabetes Association: Statistics about Diabetes from the 2011 National Diabetes Fact Sheet.

  • 8

    Centers for Disease Control and Prevention: National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, 2011.

    • Search Google Scholar
    • Export Citation
  • 9

    Mayfield JA, Reiber GE, Sanders LJ, et al: Preventive foot care in people with diabetes. Diabetes Care 21: 2161, 1998.

  • 10

    American Diabetes Association: Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts. Diabetes Care 22: 1354, 1999.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Arts ML, de Haart M, Bus SA, et al: Perceived usability and use of custom made footwear in diabetic patients at high risk for foot ulceration. J Rehabil Med 46: 357, 2014.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Tesfaye S, Chaturvedi N, Eaton SE, et al: Vascular risk factors and diabetic neuropathy. N Engl J Med 352: 341, 2005.

  • 13

    Fan L, Sidani S, Cooper-Brathwaite A, et al: Feasibility, acceptability and effects of a foot self-care educational intervention on minor foot problems in adult patients with diabetes at low risk for foot ulceration: a pilot study. Can J Diabetes 37: 195, 2013.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Pataky Z, Vischer U: Diabetic foot disease in the elderly. Diabetes Metab 33(suppl 1): S56, 2007.

  • 15

    Ulbrecht JS, Hurley T, Maurer D, et al: Prevention of recurrent foot ulcers with plantar pressure based in shoe orthoses: the CareFUL prevention multicenter randomized controlled trial. Diabetes Care 37: 1982, 2014.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Veresiu IA, Iancu SS, Bondor C: Trends in diabetes related lower extremities amputations in Romania: a five year nationwide evaluation. Diabetes Res Clin Pract 109: 293, 2015.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Rice JB, Desai U, Cummings AK, et al: Burden of diabetic foot ulcers for Medicare and private insurers. Diabetes Care 37: 651, 2014.

  • 18

    Boulton AJ, Kirsner RS, Vileikyte L: Clinical practice: neuropathic diabetic ulcers. N Engl J Med 351: 48, 2004.

  • 19

    Peters EJ, Lavery LA: Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 24: 1442, 2001.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20

    Morshed GM, Mashahit MA, Shaheen HA: Simple screening tests for peripheral neuropathy as prediction of diabetic foot ulceration. FAQJ 4: 2, 2011.

    • Search Google Scholar
    • Export Citation
  • 21

    Mayfield JA, Sugarman JR: The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract 49(suppl 11): 17, 2000.

    • Search Google Scholar
    • Export Citation
  • 22

    American Diabetes Association: Standards of medical care in diabetes—2013. Diabetes Care 36(suppl 1): S11, 2013.

  • 23

    Campbell I: Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations. Stat Med 26: 3661, 2007.

  • 24

    Richardson JT: The analysis of 2 × 2 contingency tables–yet again. Stat Med 30: 890, 2011.

  • 25

    Altman DG, Machin D, Bryant TN, et al, eds: Statistics with Confidence, 2nd ed, p 52, BMJ Books, London, 2000.

  • 26

    Sloan FA, Feinglos MN, Grossman DS: Receipt of care and reduction of lower extremity amputations in a nationally representative sample of U.S. elderly. Health Serv Res 45: 1740, 2010.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27

    McInnes A, Jeffcoate W, Vileikyte L, et al: Foot care education in patients with diabetes at low risk of complications: a consensus statement. Diabet Med 28: 162, 2011.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Lavery LA, Hunt NA, Lafontaine J, et al: Diabetic foot prevention: a neglected opportunity in high-risk patients. Diabetes Care 33: 1460, 2010.

Comparison of Diabetic Foot Care with Other Diabetic Preventive Care Services

Fayegh Jadalinull

Search for other papers by Fayegh Jadali in
Current site
Google Scholar
PubMed
Close
 MD, PhD
,
Hamid Nematinull

Search for other papers by Hamid Nemati in
Current site
Google Scholar
PubMed
Close
 PhD
,
Piran Jadalinull

Search for other papers by Piran Jadali in
Current site
Google Scholar
PubMed
Close
 BS
, and
Patrick Jadalinull

Search for other papers by Patrick Jadali in
Current site
Google Scholar
PubMed
Close
 DPM
Restricted access

Background:

Diabetes is a major chronic disease with high morbidity and mortality. Diabetic preventive care services are essential in the management and outcome of the disease. More than other preventive diabetic care services, preventive care of diabetic retinopathy has been emphasized and recommended by practitioners and insurance companies. We investigated the status of preventive care in the diabetic population.

Methods:

Information was collected from 420 outpatients aged 30 to 80 years. The patients were divided into two groups: those with well-controlled blood sugar levels (hemoglobin A1c [HbA1c] level ≤7%) and those with uncontrolled blood sugar levels (HbA1c level >7%).

Results:

Data analysis indicated that for both groups, 93% of the participants were seen for diabetic eye care at least once and 78% were getting an annual eye examination regularly. In the controlled and uncontrolled blood sugar groups, 26% and 32% of patients, respectively, had ever seen a nephrologist and 38% and 49%, respectively, had ever seen a cardiologist. In the controlled and uncontrolled blood sugar groups, 32% and 38% of patients, respectively, had visited a podiatric physician. For statistical analysis and comparison of results between the two groups, we applied the χ2 test and calculated 95% confidence intervals. There were some significant differences regarding the complications of diabetes mellitus and preventive care.

Conclusions:

There is a need for greater engagement by podiatric physicians and health-care providers to promote regular visits for the diabetic population to podiatric medical clinics.

Alamance Internal and Nuclear Medicine, Burlington, NC.

University of North Carolina at Greensboro, Bryan School of Business, Greensboro, NC.

University of North Carolina at Chapel Hill, Whitsett, NC. Mr. Jadali is now with George Washington University, MBA Healthcare, Washington, DC.

New York College of Podiatric Medicine, New York, NY.

Corresponding author: Fayegh Jadali, MD, PhD, Alamance Internal and Nuclear Medicine, 2961 Crouse Ln, Burlington, NC 27215. (E-mail: fayegh33@yahoo.com)